[1]
“Assessment of inpatient psychiatric readmission risk among patients discharged on an antipsychotic polypharmacy regimen: A retrospective cohort study”, ama, vol. 46, no. 2, pp. 133–144, Jan. 2018, doi: 10.5644/ama2006-124.198.